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Abstract: In the last few years, optimal fixation of or-
thopaedic implants evolved to preserve host bone and
enhance tissue integration by surface modifications, in-
cluding the use of coatings with bioactive ceramics. In
this work, we fabricated a novel bone-like porous bioac-
tive glass-ceramic coating on curved alumina substrates;
good joining between the two components was possible
due to the interposition of a glass-derived dense interlayer.
The mechanical properties of the porous glass-ceramic,
which mimics the 3-D pore architecture of cancellous
bone, are adequate for load-bearing applications (com-
pressive strength of 19 MPa and fracture energy around
6.5×10−4 J mm−3, with a total porosity of 62 vol.%). In vitro
bioactive behaviour was investigated by testing the sam-
ples in simulated body fluid and by evaluating the apatite
formation on the surface and pore struts of the trabecular
coating, which is a key precondition for in vivo osteointe-
gration. The concepts disclosed in the present study could
find interesting application in the context of orthopaedic
implants, with particular reference to full-ceramic acetab-
ular cups for hip joint prosthesis.
Keywords: Bioactive glass, Coating, Scaffold, Bioceramic,
Hip joint prosthesis.
1 Introduction
Bioactive glasses havebeen studied andproposed formore
than 40 years in a variety of medical applications, in-
cluding middle ear ossicle replacement, bone cements
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and, generally, non-load-bearing osseous implants [1, 2].
However, their use has been limited by poor mechanical
strength in tension and under cyclic loading. For applica-
tions where good mechanical properties are a goal, high-
strength ceramics or metal alloys are still the materials
of choice. Alumina, zirconia and composites thereof are
excellent materials for the fabrication of prosthetic joint
surfaces because of their high biocompatibility, wear re-
sistance and compressive strength [3], while titanium and
cobalt alloys are used for those components of the im-
plant, such as femur stem, which require an extensive
load-bearing ability [4]. In spite of these attractive prop-
erties, all these high-strength materials lack osteointegra-
tion, i.e. the ability to bond to living bone. Once implanted
in vivo, alumina and metal alloys induce the formation of
a non-adherent fibrous capsule at the tissue-implant in-
terface, which could involve postoperative mobility and
displacement of the prosthetic component from the cor-
rect position. Therefore, modifying the surface properties
by the deposition of a coating is a valuable approach to
improve osteointegrationwhilemaintaining unaltered the
good mechanical properties of the prosthesis. Bioactive
glasses and glass-ceramics, being known to promote a
strong chemical bond with surrounding bone and to en-
courage positive interactions between cells and implanted
device, are ideal biomaterials for the fabrication of coat-
ings [5]. Over the years, several methods have been pro-
posed to coat a substrate with a glass or glass-ceramic
layer, such as enamelling [6], plasma spraying [7], spin
coating [8], radio-frequency magnetron sputtering [9],
electrophoretic deposition [10, 11] and airbrush spray-
ing [12]. In spite of their potentiality, however, bioactive
glass coatings are still rarely applied, mainly due to some
concerns about their long-term durability and fate in vivo.
This opens new prospects for the scientific research, since
much still has to be done to benefit fully from bioactive
glass coatings.
Coatings are usually produced as dense, pore-free
glass or glass-ceramic layers; in this work, carried
out in the framework of the EC-funded project MATCh
(“Monoblock acetabular cup with trabecular-like coat-
ing”), novel bone-like glass-derived coatings are proposed
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Table 1: Starting glasses used in this work.
Glass Oxide composition (mol.%) Melting conditions CTE (×10−6∘C−1)
SiO2 CaO Na2O Al2O3 MgO P2O5
SCNA 57 34 6 3 - - 1550∘C/1 h 8.7
S50P3 50 30 14 1 2 3 1500∘C/1 h 11.3
Figure 1: Scheme of the novel prosthetic full-ceramic device pro-
posed in this work.
and investigated. Our research group first claimed the con-
cept behind this work [13], suggesting the use of a full-
ceramic single-piece acetabular cup for hip joint prosthe-
sis that could be anchored to the patient’s bone without
employing metal back, screws or poly(methyl methacry-
late) cement but by means of a bioactive trabecular coat-
ing able to promote a “physiological” osteointegration. As
schematically illustrated in Fig. 1, this new prosthetic ac-
etabular cup is constituted by three layers: (i) an alumina
substrate, (ii) a bioactive bone-like trabecular coating and
(iii) a glass-derived interlayer with the aim of improving
the adhesion between the bioceramic cup and the trabec-
ular coating. Newbone is expected to growthwithin the in-
terconnectedmacroporous network of the trabecular coat-
ing. As the trabecular layer is bioactive, a tight bond be-
tween porous coating and new bone will form in vivo.
We recently demonstrated the feasibility of this 3-layer
device in a flat geometry [14, 15]; the challenge considered
in the present work is to extend these preliminary results
to a more complex, curved configuration in a reproducible
way, which is one of the major goals of the project MATCh.
2 Materials and methods
2.1 Starting materials
The curved ceramic substrates to be coated were obtained
by cutting high-purity (> 99 wt.%) alumina crucibles in
sectors (length of the external arc: 20-40 mm; external ra-
dius: 19 mm; wall thickness: 2.0 mm; width: 10 mm) using
a diamond blade (330CA; Accutom 5 machine, Struers).
The compositions of the SCNA and S50P3 glasses used
for the preparation of interlayer and trabecular coating
are listed in Table 1. The glass reagents (high-purity ox-
ides and carbonates, all purchased from Sigma-Aldrich)
were molten in a platinum crucible in air. The melt was
quenched in cold water to obtain a frit, that was then
ground by a 6-ball zirconia milling machine and properly
sieved below a particle size of 32 µm (stainless steel sieves,
Giuliani Technologies Srl).
2.2 Dense coating (interlayer)
manufacturing
We fabricated the SCNA-derived interlayer by airbrush
spraying of glass suspensions; the details of the manu-
facturing process are reported elsewhere [12]. Briefly, a
glass-based slurry (50wt.%SCNA, 44wt.%distilledwater,
6 wt.% poly(vinyl alcohol) (PVA)) was prepared and then
layer-wise deposited on the curved alumina substrates
by an airbrush spray gun (Evolution Silverline M, Harder
& Steenbeck, Germany). Single green layers were dried at
room temperature for 1 h at the end of each spraying cy-
cle. Once all the depositions were completed, the samples
were left to dry overnight under ambient conditions; the
PVA, acting as a binder, allowed manipulating these sam-
ples (with a certain caution) for the subsequent operations
without damage or detachment of the green coating.
2.3 Trabecular coating fabrication
The bone-like porous coating was produced by the sponge
replication method, which is recognized as one of the
“gold standard” techniques to fabricate 3-D scaffolds [16–
18]. First, blocks of a commercial open-cell polyurethane
(PU) sponge (density about 20 kgm−3) were cut in the form
of planar strips by using a razor blade; then an appropri-
ate, permanent curvature was imparted to these templates
so that they could match the shape and size of the curved
alumina substrates. Specifically, the PU sponge was ther-
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Figure 2: Joining of the glass-loaded sponge to the curved substrate
by stitching: this method can be applied to (a) small-sized or (b)
large-sized samples.
mally pre-formed by applying a heat treatment at 200∘C
for 1 h using the alumina curved substrate as a direct
mould; afterwards, the curvature was permanently main-
tained by the polymeric template [19]. In order to take into
account the volumetric shrinkage due to scaffold sinter-
ing, thedimensions (length andwidth) of the sponge strips
were properly oversized of around 30% with respect to
those of alumina curved substrates. The curved PU strips
were then soaked into an aqueous suspension contain-
ing S50P3 powder sieved below 32 µm (slurry formulation:
30 wt.% glass, 6 wt.% PVA used as a binder, 64 wt.% dis-
tilled water) and compressed up to 60% in thickness for
two times (the load was applied for 1 s first on the convex
and then on the concave face of the sponge). This infiltra-
tion/compression cycle was repeated for three times fol-
lowed by a final cycle of impregnation only. During each
compression, the curvature of the sponge was temporar-
ily cancelled and it became a planar strip again; after re-
moving the compressive load, the curvature was success-
fully restored. After the endof thewhole process, the glass-
coated sponges were left to dry overnight under ambient
conditions.
Porous S50P3 cuboids (side around 10 mm) were also
produced, according to the same schedule processing, to
characterize the new glass-derived scaffold from morpho-
logical, mechanical and bioactive viewpoints using a sim-
plified cubic geometry.
The 3-layer construct schematically depicted in Fig. 1
was produced by joining SCNA-coated curved alumina
samples and S50P3-loaded sponges together by stitching
with a nylon thread (Fig. 2). Finally, the whole system
was thermally-treated at 1000∘C for 3 h (heating and cool-
ing rates set at 5 and 10∘C min−1, respectively) to allow
burning-out of the PU template and the nylon thread, as
well as sintering of glass powders and the formation of
alumina/interlayer and interlayer/trabecular coating sta-
ble interfaces.
2.4 Characterisation
Both as-cast S50P3 and S50P3-derived scaffolds (ground
in powder) underwent wide-angle X-ray diffraction anal-
ysis (2θ within 10-70∘) using a X’Pert diffractometer oper-
ating at 40 kV and 30 mA (Bragg-Brentano camera geom-
etry with Cu Kα incident radiation, incident wavelength
λ = 0.15405 nm, step size ∆(2θ) = 0.02∘, fixed count-
ing time of 1 s per step). Phase identification was per-
formed by using X’Pert HighScore software equipped with
PCPDFWIN database.
Differential thermal analysis (DTA) was carried out
on 50 mg of glass powder by using a DTA7 Perkin-Elmer
instrument (temperature range: 50-1300∘C; heating rate:
20∘C min−1). Pure alumina powder (Sigma-Aldrich) was
used as a reference material and for baseline determina-
tion. The characteristic temperatures of S50P3, i.e. glass
transition temperature (Tg), onset crystallization temper-
ature (Tx) and peak crystallization temperature (Tc), were
assessed directly from the DTA plot.
The sintering process of a glass powder compact was
monitored by hot-stage microscopy (HSM) (Expert System
Solutions instrument) performed in air atmosphere to ap-
proximate the chemo-environmental conditions of the fur-
nace chamber during the scaffold (trabecular coating) heat
treatment. This analysis provides useful information for
selecting the appropriate sintering temperature in order
to obtain, at least ideally, scaffolds with well-densified
trabeculae, high mechanical strength and adequate pore
content for bone tissue engineering applications. HSM al-
lows quantifying the shrinkage upon sintering by mea-
suring the variation of specimen size during a controlled
heating process (temperature range 50-1300∘C and heat-
ing rate 20∘C min−1, consistently with DTA). The sample
for HSM analysis was prepared by manually pressing the
glass powder using a small cylindrical mould (base diam-
eter ˜1 mm, height ˜3 mm). Sample shrinkage at different







where A0 is the area of the sample silhouette at room tem-
perature and AT is the sample area at the temperature T.
S50P3 scaffolds were metal-coated and analysed from
a morphological viewpoint by scanning electron mi-
croscopy (SEM, Philips 525 M; working voltage: 15 kV) to
investigate the surface morphology and assess pore/strut
size and shape.
The inner porous network was also non-destructively
investigated by micro-computed tomography (micro-CT;
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SkyScan 1174, Micro Photonics Inc.). Sample volume re-
construction and 3-D visualization were performed by
making use of N-Recon and CT-Vox softwares, respectively.
The volumetric shrinkage of the scaffolds,
∆Sscaold (%), due to the polymeric template removal and






where V0 is the volume of the glass-impregnated sponge
before sintering and V s is the volume of the sintered scaf-
fold.
The porosity content P (vol.%) was calculated by






where ρb is the density of bulk material and ρs is the ap-
parent density of the scaffold (mass/volume ratio).
The strength of the scaffolds was evaluated through
crushing tests on 10 mm × 10 mm × 10 mm polished
cuboids (Synthec 10/D apparatus, 5-kN cell load, cross-
head speed set at 1 mm min−1). The compressive failure
stress, σc (MPa), was calculated as
σc = LMAR
(4)
where LM (N) is the maximum load registered during the
test and AR (mm2) is the resistant cross-sectional area.
The energy per unit volume W (J mm−3) absorbed by
the scaffold till the breaking off is reached was defined as
the energy necessary to deform a specimen from the un-
loaded condition to the failure strain εf andwas calculated





where the strain ε is the integration variable; the initial
condition is σ(ε = 0) = 0 and the final state σ(ε = εf ) = σc
(calculated from Eq. 4). The above-mentioned mechanical
parameters were expressed as mean value ± standard de-
viation calculated on five samples.
In vitro tests were carried out by soaking the scaf-
folds in simulated body fluid (SBF) prepared according to
Kokubo’s protocol [21]. S50P3 porous cuboids (side around
10mm)were soaked for 7 and 28days in 30ml of SBFmain-
tained at 37∘C in polyethylene bottles. Every 48 h the sam-
ples were extracted from the bottles, gently rinsed with
some drops of distilled water and then soaked in 30 ml of
new SBF. Periodic replacement of SBF is a common experi-
mental practice to simulate fluid circulation in the human
body [14, 18] as the cation concentration in the solution
progressively decreases during the experiment as a result
of changes in the sample surface chemistry.
The pH of the solutionwasmonitored daily. At the end
of the experiment, the samples were left to dry at room
temperature and then investigated by SEM and energy dis-
persive spectroscopy (EDS, Philips EDAX 9100) for compo-
sitional analysis. Mass loss and compressive strength of
S50P3 scaffolds soaked for 1 month in SBF were also as-
sessed.
Selected samples from in vitro tests and complete
curved samples were embedded in epoxy resin (Epofix,
Struers), cut with a diamond blade (Accutom 5 cyttingma-
chine, Struers) and polished using #600 to #4000 SiC grit
paper; the obtained cross-sections were metal-coated and
then analysed by SEM in back-scatteringmode to enhance
the discrimination among the different layers.
3 Results
A comprehensive characterization of SCNA has been re-
ported elsewhere by the authors [14, 15]. The characteris-
tic temperatures of SCNA are Tg = 690∘C, Tx = 820∘C and
Tc = 856∘C. The thermal treatment applied in this work
(1000∘C for 3 h) induced the development of one crys-
talline phase identified as wollastonite (CaSiO3) [14, 15].
Therefore, SCNAcrystallizes formingaglass-ceramic inter-
layer.
In this work, sintering and crystallization of the new
glass S50P3 were investigated for the first time. While de-
signing glass composition, we analytically estimated the
coefficient of thermal expansion (CTE) by making use of
the program Priven2000 (SciGlass software), in order to
avoid a too high mismatch with the CTE of the interlayer
(Table 1).
The characteristic temperatures of S50P3, assessed by
DTA and marked in Fig. 3a, are Tg = 620∘C, Tx = 730∘C
and Tc = 810∘C. A quantitative evaluation of S50P3 shrink-
agedependingon the sintering temperature canbederived
from the curve plotted in Fig. 3b, showing that S50P3 ex-
hibits a 1-step densification behaviour. Specifically, den-
sification begins at Tg ≈ TFS (first shrinkage) and is fully
completed when crystallization starts at Tx ≈ TMS (max-
imum shrinkage). We estimated that the shrinkage up to
TMS was around 37%. The sintering temperature for pro-
ducing S50P3 scaffolds (1000∘C) was chosen slightly after
the end of the plateau following the maximum densifica-
tion.
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Figure 3: Thermal analyses performed on S50P3 glass: (a) differen-
tial thermal analysis (DTA) and (b) hot-stage microscopy (HSM).
Figure 4: XRD pattern of (a) as-cast S50P3 and (b) S50P3 scaffold
produced by thermal treatment at 1000∘C for 3 h and subsequently
ground in powder.
As-poured S50P3 is a completely amorphous material
(glass), as demonstrated by the broad halo in the XRD
pattern shown in Fig. 4a. Three crystalline phases, identi-
fied as wollastonite (CaSiO3, code 00-027-0088), calcium-
sodiumsilicate (Na15.78Ca3(Si6O12), code 01-078-1650) and
rhenanite (NaCaPO4, code 00-029-1193) were detected in
Figure 5:Morphological investigation of S50P3 scaffolds: (a) camera
picture of a typical porous cuboid (side around 10 mm); SEM micro-
graphs of (b) scaffold surface (magnification 50×), (c) a well-sintered
trabecula (1200×) and (d) cross-section showing the interconnectiv-
ity of the pores (600×).
the material sintered at 1000∘C for 3 h (Fig. 4b). There-
fore, it should be taken into account that, after the ther-
mal treatment, S50P3 was converted into a glass-ceramic
material; however, for purpose of simplicity, hereafter we
will use expressions such as “S50P3 scaffold” without any
further specification.
A typical S50P3 porous cuboid is shown in Fig. 5a. The
volumetric shrinkage was 65.9 ± 2.2%, and the total poros-
ity was 62.1 ± 2.4 vol.%. In both cases, the low values of
standard deviation demonstrate the good reproducibility
of the samples. The SEM micrographs reported in Fig. 5b-
d show that an excellent densification of the scaffold struts
was achieved, with a 3-D pore architecture that closely
reproduces the trabecular structure of cancellous bone.
Fig. 5d suggests that the pores are interconnected, with
size above 100 µm, thus allowing bone cells to colonize the
implant and bone tissue to regenerate inside the scaffold
in an in vivo scenario.
The scaffold is strong enough to be cut neatlywith adi-
amond blade (Fig. 5d) without any apparent damage to the
structure. The compressive strength of S50P3 cubic scaf-
folds was 19.1 ± 2.7 MPa, and the mean fracture energy (as-
sessed from the stress-strain curves) was 6.5×10−4 J mm−3.
A typical example of compressive stress-strain curve
for S50P3 scaffolds is reported in Fig. 6. The curve exhibits
a multi-peak profile, which is peculiar of cellular ceram-
ics [22]. The curve has a positive slope up to a first peak,
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Figure 6: Typical stress-strain curve for S50P3 cubic scaffolds.
then the thinnest trabeculae begin to crack causing an ap-
parent stress drop (negative slope). However, the scaffold
is still able to withstand higher loads and, therefore, the
stress rises again. The repetition of this behaviour pro-
duces a jagged stress-strain curve while the progressive
cracking of scaffold struts occurs.
After soaking for 7 days in SBF, the scaffold struts
were coated by a well-distinguishable layer of a newly
formed phase, which also grew on the walls of the inner
pores of the scaffold (Figs. 7a and 7b). Compositional anal-
ysis reveals that this layer is rich in Ca and P (Fig. 7d).
After soaking for 1 month in SBF, the thickness of this
CaP layer seems be higher compared to the previous time
point (around 20 vs. 10 µm). The peak of Si, associated
to the presence of a silica gel layer after 7 days in SBF
(consistently with the mechanism of bioactivity of silicate
glasses [1]), is no longer detectable after 1monthof soaking
(Fig. 7f). At the end of the experiment, the Ca/P ratio was
equal to 1.2 at.%, which is typical of Ca-deficient hydrox-
yapatite (HA) formed on bioactive glasses. The increment
of the pH of the solution is moderate; pH reaches values
around 7.70 by the first 10 days of soaking and then pro-
gressively decreases.
Low tendency of S50P3 scaffolds to dissolve upon
soaking inbiologicalmediawas further confirmedbymass
loss assessment. After 1-month immersion, mass loss of
about 2% was registered, which involved a very moderate
decrease of the compressive strength compared to that of
untreated samples (–10%).
Complete curved samples were produced by stitch-
ing (Fig. 2) followed by thermal treatment. From a qual-
itative viewpoint, good joining at the alumina/SCNA in-
terlayer and SCNA interlayer/S50P3 trabecular coating in-
terfaces was observed (Fig. 8). Sintered curved samples
could be manipulated without any particular problem, as
the trabecular coating seemed to be tightly attached to the
SCNA/alumina substrate lying underneath. Fig. 8d shows
that the interlayer/trabecular coating interface was not
distinguishable in correspondence of the contact areas be-
tween SCNA and S50P3, which confirms the good qual-
ity of the joining in these points. A few isolated defects,
visible in Figs. 8a and 8b, are due to the stitching thread
which created small perforations through the glass-loaded
sponge, resulting in full-thickness holes and local crum-
bling of the trabecular coating upon heat treatment. Small
closedpores visible in the trabecular coating are due to gas
development associated to polymer sponge burn-off. The
presence of closed pores also in the interlayer is due to PVA
removal and air entrapment during the airbrush spray-
ing process, as already observed elsewhere [12]. Micro-
CT investigations revealed that a trabecular coating with
quite homogeneous thickness (around 2 mm) can be suc-
cessfully produced with the method proposed (Figs. 9a
and 9b). The porous coating exhibited a continuous 3-D
trabecular-like structure, which is very close to that of can-
cellous bone (Fig. 9c). Micro-CT analysis, performed in a 3-
D space, is complementary to SEM investigation that pro-
vides information on a single 2-D cross-section of the sam-
ple. Fig. 9c puts in evidence the high interconnectivity of
the trabecular coating macropores, which is a key require-
ment to allowbone cells to colonize the implant in vivo and
the new bone to grow inside the pores.
4 Discussion
The composition of the new biomedical glass S50P3 was
designed starting from that of the parent glass SCNA
(Table 1), which was widely studied by the authors for
biomedical applications [12, 14, 15, 19]. Our aim was to ob-
tain a material with good mechanical and bioactive prop-
erties, while SCNA (in its both glassy and glass-ceramic
forms) is mechanically strong but just weakly bioactive.
Therefore, we decreased the content of silica (a dramatic
decrease of the bioactivity kinetics was observed when
glass composition exceeds 53mol.% of silica [23]) and alu-
mina (the presence of which is known to stabilize the glass
network, thereby decreasing surface reactivity [24]), and
increased the content of Na2O (Na+ ions are known to play
a key role in the early stages of the bioactivity mechanism
in silicate glasses [1]). MgO was introduced because of the
beneficial effect of magnesium in stimulating osteoblast
activity [25]. P2O5 was useful on one hand to further im-
prove glass bioactivity interrupting locally the silica net-
work and, accordingly, increasing glass reactivity and, on
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Figure 7: In vitro bioactivity of S50P3 scaffolds after soaking in SBF for (a-c) 7 days and (d-f) 28 days. SEM micrographs, acquired in back-
scattering mode, refer to polished cross-sections of the samples embedded in epoxy resin; the magnifications are (a) 300×, (b) 1300×, (d)
400×, (e) 500×. EDS patterns in (c,f) refer to the newly formed layer on the scaffold struts marked in the SEM pictures (the peak of Ag is due
to the metal costing needed for the analysis; the peak of C is attributable to resin-related boundary effect).
Figure 8: Complete curved samples (alumina substrate + SCNA
interlayer + S50P3 trabecular coating) after sintering at 1000∘C for
3 h: camera pictures of (a) small-sized and (b) large-sized samples;
(c) SEM micrograph (back-scattering mode) of a polished cross-
section after embedding the sample in epoxy resin (50×) and (d)
detail of a contact area between interlayer and trabecular coating
(200×).
Figure 9:Micro-CT reconstruction of a portion of the S50P3 trabec-
ular coating “separated” from the substrate (coating thickness
around 2 mm): (a) frontal view, (b) perspective view, (c) detail show-
ing the bone-like 3-D structure and the high interconnectivity of the
pores.
the other hand, to adjust the CTE in order to avoid a too
high mismatch with the CTE of SCNA.
Following a strategy adopted in previousworks [14, 15]
and also proposed by other authors [26], we inserted a
“bond coat” (SCNA-derived interlayer) having intermedi-
ate CTE between top layer (S50P3 trabecular coating) and
alumina substrate (CTE around 8.5×10−6∘C−1) in order to
overcome CTE mismatch problems.
Upon thermal treatment at 1000∘C for 3 h, SCNA
and S50P3 partially crystallize giving glass-ceramic ma-
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terials. Wollastonite, the major crystalline phase devel-
oped in both SCNA interlayer [14, 15] and S50P3 scaf-
folds (Fig. 4b), is known to be highly biocompatible [27].
Rhenanite (Fig. 4b) is not only biocompatible [28] but is
also known to transform into HA after reacting with water,
thus being a nucleation precursor for HA formation [29].
Hence, no problems of possible cytotoxicity associated to
the types of crystalline phases contained in the interlayer
and scaffold (trabecular coating) materials are foreseen.
We found the sponge replication a highly suitable
method to process S50P3 in the form of strong, porous
scaffolds with 3-D trabecular architecture that closely
mimicked that of cancellous bone (Fig. 5). Total porosity
(around 62 vol.%) and pore size (large macropores above
100 µm)were in the ranges usually recommended for bone
tissue engineering scaffolds [30].
The compressive strength of S50P3 scaffolds (around
19MPa) is above the standard reference range usually con-
sidered for cancellous bone (2-12 MPa [1]) as well as most
of foam-like scaffolds with a comparable pore content re-
ported in the literature [31, 32]. This can be attributable to
the higher silica content and to the presence of a small
amount of alumina as an intermediate oxide, which is
known to have a strengthening effect on the glass network.
The high compressive strength suggests the suitability of
S50P3 scaffolds as trabecular coatings for load-bearing
prosthetic applications. The fracture energy of S50P3 scaf-
folds (around 6.5×10−4 J mm−3) is comparable to that as-
sessed for SCNA scaffolds with the same porosity [33], but
is significantly higher (more than one order of magnitude)
than that of HA [34] and phosphate glass scaffolds [35] re-
ported in the literature.
The good in vitro bioactivity of S50P3 scaffolds is
demonstrated by the formation of an apatite-like layer on
the pore struts (Fig. 7), which is a sort of precondition
so that a stable interfacial bond to bone may develop in
vivo [23]. Furthermore, the growth of apatite on the struts
of the inner pores of the scaffold represents an indirect
evidence of the high pore interconnectivity, which is a
crucial feature for porous implants intended to biointe-
grate with bone. Mild increase of the pH of SBF (7.70)
due to ion-exchange phenomena with the bioactive glass-
ceramic surface could even be beneficial in vivo, as mod-
erate alkaline conditions (pH up to 7.8) can stimulate os-
teoblast activity [36].
The decrease of compressive strength due to minimal
in vitro dissolution of S50P3 scaffolds is very moderate,
which suggests adequate maintenance of integrity upon
prolonged contact with biological fluids.
In a previous work [14] we also assessed the mass loss
of SCNA glass-ceramic scaffolds after long-term soaking in
SBF. After soaking for 3 months in SBF, the mass loss of
SCNA scaffolds was about 3%. This confirms the high sta-
bility of thematerial, characterized by a verymoderate sol-
ubility in SBF.
The very low tendency of S50P3- and SCNA-based
glass-ceramics to dissolve in aqueous media can be at-
tributable to the high chemical stability of the alumina-
containing glassy phases. Therefore, no problems of dura-
bility and overall integrity of the 3-layer device are fore-
seen after implantation. On the other hand, it cannot be
ignored that in vitro results are indeed useful but offer, un-
avoidably, only an estimate of what happens in an in vivo
scenario. For example Liu et al. [37] implanted 13-93 scaf-
folds in rats and observed that the brittle response of as-
such and in vitro samples changed to an elasto-plastic be-
haviour after 2-4 weeks in vivo. This is due to the fact that
the cells adherent on the trabecular coating, the newly
formed bone and the scaffold itself create a “living” bio-
composite in situ.
Release of Mg2+ ions from the glassy phase of S50P3
trabecular coating is expected to stimulate osteoblast ac-
tivity in vivo and, accordingly, new bone formation [25].
In summary, the novel glass S50P3 was designed
to give good mechanical and bioactive properties. Both
scopes were achieved, as the S50P3 (glass-ceramic) scaf-
fold was strong and the HA layer formation upon soak-
ing in SBF suggests that the parent S50P3 glass actually
gives a bioactive glass-ceramic, thus the compositional
design was successful. The sponge replication technique
combined with stitching (Fig. 2) represents a novel, cre-
ative and interesting approach to produce bioactive glass-
derived trabecular coatings on curved substrates. How-
ever, the method has to be optimized to solve some short-
comings, such as the lownumber of contact areas between
interlayer and porous coating and the lack of full integrity
of the trabecular layer – especially for large sample sizes
(Fig. 8).
5 Conclusions
In the present work, we proposed to make use of glass-
derived scaffolds as trabecular coatings on curved alu-
mina substrates, with the aim of inducing biological fix-
ation of bioceramic prostheses to bone. The feasibility of
bone-like trabecular coatings in a curved geometry using
the sponge replication method was successfully demon-
strated. The trabecular coating showed to be bioactive in
vitro and strong enough to be safely manipulated without
any apparent damage. The results presented in this work
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provide an important stimulus for the research in the field
of bioceramic implants; the next step of this research will
be extending these achievements to a semi-spherical con-
figuration typical of the real acetabular component of hip
joint prosthesis.
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